Congenital Variant of Rett Syndrome
The congenital variant of Rett syndrome is caused by mutations in the FOXG1 gene, not MECP2, and presents with severe symptoms from birth or the neonatal period, distinguishing it from classic Rett syndrome which has a period of normal early development.
Genetic Etiology
FOXG1 gene mutations are responsible for the congenital variant of Rett syndrome 1. FOXG1 encodes a brain-specific transcriptional repressor essential for early telencephalon development. While classic Rett syndrome results from MECP2 mutations on the X chromosome, the congenital variant represents a distinct genetic entity with overlapping clinical features 1, 2.
Clinical Presentation
The congenital variant differs fundamentally from classic Rett syndrome in its timing and severity:
Key Distinguishing Features:
- Onset from birth or neonatal period - no period of normal development 2, 3
- Severe early-onset microcephaly (-3 to -6 standard deviations) 3
- Profound generalized hypotonia from infancy 2, 3
- Severe psychomotor impairment - inability to sit unaided or develop speech 2
- Hyperkinetic movement disorder with hand stereotypies and jerky upper limb movements 2
- Early irritability in the neonatal period 2
Neuroimaging Findings:
Brain MRI characteristically shows:
- Delayed myelination
- Hypoplasia of the corpus callosum
- Frontal lobe hypoplasia/atrophy
- Ventriculomegaly 2, 3
Additional Features:
- Peculiar dysmorphic phenotype 3, 4
- Hand-to-mouth stereotypic movements (appearing around 12 months) 3
- Frequent respiratory infections and obstructive sleep apnea 3
- Variable seizure presentation 4
Diagnostic Approach
When evaluating a patient with suspected Rett syndrome who tests negative for MECP2 and CDKL5 mutations, particularly with congenital onset, FOXG1 gene testing is mandatory 3. Approximately 92% of patients with FOXG1 mutations present with the congenital form characterized by severe hypotonia, early acquired microcephaly, and distinctive phenotype 3.
Gender Considerations
Unlike classic Rett syndrome which affects almost exclusively females, FOXG1 mutations have been identified in male patients as well 4, 5. This represents an important clinical distinction, as the congenital variant should be considered in males presenting with compatible features.
Molecular Mechanisms
FOXG1 and MeCP2 share common molecular mechanisms during neuronal development, with partially overlapping expression domains in postnatal cortex and similar neuronal subnuclear localization 1. Both disorders likely involve imbalances in excitatory/inhibitory signaling and aberrant neurodevelopment 6.
Clinical Trajectory
The natural history differs from classic Rett syndrome. Some patients show progressive improvement in visual contact and environmental interest over time, with potential for partial axial tone control and hand grasping by age 5 years, though severe developmental limitations persist 3.
Importance of Molecular Diagnosis
Confirming FOXG1 mutations provides:
- Definitive diagnosis distinguishing this from classic Rett syndrome
- Accurate genetic counseling for families
- Appropriate prognostic information
- Potential eligibility for future targeted therapies 3